Vaccine Update Newsletter Archive
Technically Speaking: 6 Tips for Sustaining Change in QI Efforts
Get 6 tips for sustaining QI efforts.
Vaccine Resources: A Webinar to Prepare for Respiratory Virus Season and a Podcast about HPV
Find out about a webinar related to preparing for fall viral season and listen to a podcast about the importance of HPV vaccination.
Vaccine Resources: Trainings, Toolkits and More
View key findings from NACCHO’s report on immunization capacity in local health departments. Find other resources, including training opportunities and strategies for improving vaccination rates in schools.
On the Bookshelf — Reader, Come Home: The Reading Brain in a Digital World by Maryanne Wolf
Find out about the differences in reading between physical and digital resources, and see what this reading scientist suggests for teaching today’s children.
Technically Speaking: A Challenge from Immunize.org
Take this challenge to find information needed during four clinical encounters and learn about resources offered by Immunize.org.
In the Journals: Recent (Yet to Be Reproduced) Data Increase Concerns about Circulating H5N1
Find out about a study that evaluated a particular strain of H5N1 influenza virus and why the findings were worrisome.
News & Views — Using Artificial Intelligence in Vaccine Education: The Good, the Bad and the Unexpected
Read about potential applications, areas of promise, and areas of concern when using AI to find vaccine information.
Vaccine Resources: New MMWRs, SAGE Report, and CME on Vaccine Coverage and Exemptions
Check out CDC’s reports on meningococcus and mpox, a summary of SAGE’s report on global immunization, and an opportunity to obtain continuing education credits.
On the Bookshelf: “The Ancient Art of Thinking for Yourself” by Robin Reames
Written in an approachable and engaging manner, this book offers many thought-provoking ideas about the power of words and how we communicate with each other. Find out more.
Technically Speaking: What Is Pemivibart?
Find info and resources about Pemivibart, a long-acting monoclonal antibody against the spike protein of SARS-CoV-2.